On ECHEMI
Home > Drugs > Tremella fuciformis enteric-coated capsules

Tremella fuciformis enteric-coated capsules

Function and Efficacy

This product is a basidiomycete polysaccharide immunopotentiator, which has the effect of improving the body's immune function and increasing white blood cells. Animal experimental studies have shown that it can treat leukocytopenia caused by hydrochloric acid nitrogen mustard and cyclophosphamide in rabbits; it can promote the recovery of hematopoietic function in mice, dogs, and monkeys after γ-ray irradiation and improve the survival rate; it can significantly improve the phagocytic function of mice's reticular and cells, increase the number of monkeys' peripheral lymphocytes, the formation rate of rosettes and EAC rosettes in macaques' peripheral blood, increase the levels of immunoglobulins and serum total complement, and has a preventive and therapeutic effect on leukocytopenia in rats caused by cyclophosphamide; it has the effect of promoting antibody production in normal and tumor-bearing mice, can activate spleen function, and enhance specific and non-specific immune responses.

Ingredients

This product contains Tremella fuciformis spore sugar and anhydrous glucose.

Name Description Content CAS NO. Manufacturer
D(+)-GlucoseExcipients

This product is a basidiomycete polysaccharide immunopotentiator, which has the effect of improving the body's immune function and increasing white blood cells. Animal experimental studies have shown that it can treat leukocytopenia caused by hydrochloric acid nitrogen mustard and cyclophosphamide in rabbits; it can promote the recovery of hematopoietic function in mice, dogs, and monkeys after γ-ray irradiation and improve the survival rate; it can significantly improve the phagocytic function of mice's reticular and cells, increase the number of monkeys' peripheral lymphocytes, the formation rate of rosettes and EAC rosettes in macaques' peripheral blood, increase the levels of immunoglobulins and serum total complement, and has a preventive and therapeutic effect on leukocytopenia in rats caused by cyclophosphamide; it has the effect of promoting antibody production in normal and tumor-bearing mice, can activate spleen function, and enhance specific and non-specific immune responses.

More
50-99-7 15

Appearance

This product is an enteric-coated capsule, the contents of which are light brown to brown amorphous powder; slightly odorous and tasteless.

Indication

1. Anti-tumor adjuvant drug for leukopenia caused by chemotherapy, radiotherapy and other reasons. 2. It can also be used as an adjuvant treatment for chronic persistent hepatitis and chronic active hepatitis.

Usage and Dosage

Oral administration: 1g at a time, 3 times a day, or as directed by a doctor.

Adverse Reactions

Some cases experience discomfort such as dry mouth and dry throat.

Precautions

It is contraindicated for those who are allergic to this product.

Special Population Medication

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Drug Interactions

Not yet clear

Storage

Seal tightly and store in a cool, dry place.

Packaging Specification

0.25g

Validity Period

24 months

Manufacturer

Beijing Yuanda Jiuhe Pharmaceutical Co., Ltd.

  • Founded in:

    1997-05-16
  • Address:

    No. 8 Jingbao Road, Doudian, Fangshan District, Beijing
  • Tax NO.:

    9111011163379631XD
  • Registered Funds:

    20 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.